Cancer Clinical Trial - Tracon 4309ST101

Status:

Open

ClinicalTrials.gov:

NCT03835949

CONDITION(S): Advanced Solid Tumors - TRIAL: Tracon 4309ST101 - Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

This is a multicenter, open label, Phase 1 dose escalation study of TJ004309 in combination with standard dose atezolizumab in patients with advanced or metastatic cancer in patients who are refractory to or intolerant to all available therapy.

Drug

TJ004309; Atezolizumab

Trial Type

Interventional

Condition

Advanced solid tumors

Keywords

Advanced solid tumors | TJ004309 | Atezolizumab | Tracon